This webinar was tailored for nurses aiming to deepen their understanding of medication access and treatment decision-making. It explored the different ways medications are accessed in Australia, including the Pharmaceutical Benefits Scheme and the Therapeutic Goods Administration, introduced the concept of personalised medicine, and discussed treatment decision-making for stage II, stage III and advanced melanoma. Nurses will gain insight into treatment decision pathways and how therapies are selected based on patient-specific factors such as financial ability, assessments of survival, treatment availability, and side-effect and toxicity profiles, equipping them to offer comprehensive care and patient education as critical members of the multidisciplinary team.
Watch on demand
Event recording
Recording guide
Explore the topics
Open the guide below to see the seven topics covered, then select any topic to open the recording at that point on YouTube in a new tab.
Show the 7 topicsHide the topics
Learning outcomes
What you will learn
After this session, nurses will be able to:
01
Understand medication access in Australia
Explain the different ways anti-cancer medications are accessed in Australia, including through the Pharmaceutical Benefits Scheme and the Therapeutic Goods Administration.
02
Comprehend personalised medicine
Describe the concept of personalised medicine and what it means for treatment decision-making in melanoma.
03
Analyse treatment decision pathways
Analyse how therapies are selected for stage II, stage III and advanced melanoma, based on patient-specific factors such as financial ability, assessments of survival, treatment availability, and side-effect and toxicity profiles.
04
Apply knowledge to patient education
Use this knowledge to offer comprehensive care and patient education as a critical member of the multidisciplinary team.
At a glance
The event in brief
Originally held
Tuesday 16 December 2025
Online webinar, part of the National Melanoma Nursing Program.
Who this is for
Nurses
Nurses aiming to deepen their understanding of medication access and treatment decision-making in melanoma.
Contributors
Speaker
Speaker
Dr Piyush Grover
Medical Oncologist, Fiona Stanley Hospital and Sir Charles Gairdner Hospital
Dr Piyush Grover is a Medical Oncologist at Fiona Stanley Hospital and Sir Charles Gairdner Hospital with a focus on melanoma, upper gastrointestinal cancers, neuroendocrine tumours and immuno-oncology. Piyush moved to Perth from New Zealand to study medicine at the University of Notre Dame and graduated with First Class Honours. He completed physician training at various Perth hospitals before undertaking a clinical and research fellowship at Melanoma Institute Australia. On returning to Western Australia, he undertook the WA Cancer and Palliative Care Network research fellowship and is pursuing a PhD in Immuno-Oncology. Prior to medicine, he worked as a clinical pharmacist and was the runner-up for New Zealand’s Young Pharmacist of the Year in 2011.
This webinar was brought to you by
Resource details
